The Effect of Telmisartan and Ramipril on Early Morning Blood Pressure Surge: a Pooled Analysis of Two Randomized Clinical Trials.
From: Hypertension Unit, Saint-André Hospital, Bordeaux, France. philippe.gosseechu-bordeaux.fr
Blood pressure monitoring
- Publish Date: Jun 2007
- ISSN: 1359-5237
- Volume: 12
- Issue: 3
- Pages: 141-7
- Medium: Print
- Language: English
- Citation (JAMA): Gosse Philippe, Neutel Joel M, Schumacher Helmut, et al. The Effect of Telmisartan and Ramipril on Early Morning Blood Pressure Surge: a Pooled Analysis of Two Randomized Clinical Trials.. Jun 2007;12:141-7
Abstract
OBJECTIVES: The period of early morning blood pressure surge is associated with a higher incidence of cardiovascular events than at other times of the day. Antihypertensive medication given once daily in the morning may not protect against this surge if its duration of action is too short. We compared telmisartan, an angiotensin II receptor blocker with a trough-to-peak ratio >90%, with ramipril, an angiotensin-converting enzyme inhibitor with a trough-to-peak ratio of around 50%. METHODS: Data from two prospective, randomized, open-label, blinded endpoint studies comparing telmisartan force titrated to 80 mg once daily and ramipril 10 mg once daily were pooled. Patients had mild-to-moderate hypertension and were assessed using 24-h ambulatory blood pressure monitoring at baseline and endpoint. Early morning blood pressure surge was defined as the difference between mean blood pressure within 2 h after arising and night-time low. Patients were grouped into quartiles according to their baseline systolic surge. RESULTS: Data from 1279 patients were analyzed. Telmisartan changed the overall mean (SE) systolic surge by -1.5 (0.47) mmHg, and ramipril by +0.3 (0.47) mmHg (P=0.0049). The magnitude of surge reduction was greatest in the quartile with highest baseline systolic surge: telmisartan -12.7 (0.91), ramipril -7.8 (1.02) mmHg (P=0.0004). Telmisartan also reduced the surge compared with ramipril in dippers, but there were no differences between the two groups in nondippers. CONCLUSIONS: Telmisartan significantly reduced the early morning systolic blood pressure surge compared with ramipril. A reduction in this surge may help to reduce cardiovascular events in the morning period.
Mesh Headings (Keywords): Adult, African Continental Ancestry Group, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Asian Continental Ancestry Group, Benzimidazoles, Benzoates, Blood Pressure, Blood Pressure Monitoring, Ambulatory, Circadian Rhythm, European Continental Ancestry Group, Female, Humans, Hypertension, Male, Middle Aged, Ramipril, Time Factors
Check for Full Text / PubMed Unique Identifier (PMID): 17496463
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.